Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP was delisted on the 7th of March, 2019.
78 hedge funds and large institutions have $76.2M invested in Synergy Pharmaceuticals, Inc Common Stock in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 14 closing their positions.
7% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 14
5% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 22
2% more capital invested
Capital invested by funds: $74.6M → $76.2M (+$1.62M)
0% more funds holding
Funds holding: 78 → 78 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $84K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.09M |
| 2 |
Morgan Stanley
New York
|
+$589K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$584K |
| 4 |
Renaissance Technologies
New York
|
+$479K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$434K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$6.62M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.31M |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
-$852K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$431K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$346K |
SGYP Hedge Fund Activity: Q4 2014 in Review
78 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) for Q4 2014, worth a combined $76.2M — up 2.2% from $74.6M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new SGYP positions and 14 closed out — a net gain of 1 holder — while 23 added to existing stakes and 22 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $1.09M. The largest seller was State Street, cutting an estimated $6.62M.
- 78 institutional investors held Synergy Pharmaceuticals, Inc Common Stock (SGYP) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $76.2M of Synergy Pharmaceuticals, Inc Common Stock stock for Q4 2014, up 2.2% quarter-over-quarter.
- 15 funds opened new Synergy Pharmaceuticals, Inc Common Stock positions in Q4 2014 and 14 closed out, a net change of +1 holder.
- The largest Synergy Pharmaceuticals, Inc Common Stock buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $1.09M added.
- The largest Synergy Pharmaceuticals, Inc Common Stock seller in Q4 2014 was State Street, an estimated $6.62M sold.
Based on aggregated 13F filings for Q4 2014.